F. Hoffmann-La Roche Ltd
Hetero
GlaxoSmithKline
Eli Lilly and Company
Pfizer
Alnylam Pharmaceuticals
Allergan plc
Biocon Limited
Bristol-Myers Squibb Company
Novartis AG
AstraZeneca plc
Celgene
Merck & Co
Amgen
Published | Pages | Publisher | Report code |
---|---|---|---|
Dec 2019 | 200 | TBRC | ASDR-499018 |
F. Hoffmann-La Roche Ltd
Hetero
GlaxoSmithKline
Eli Lilly and Company
Pfizer
Alnylam Pharmaceuticals
Allergan plc
Biocon Limited
Bristol-Myers Squibb Company
Novartis AG
AstraZeneca plc
Celgene
Merck & Co
Amgen